Nature Communications (Oct 2018)

Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors

  • Zhifen Cui,
  • Yu Zhang,
  • Kai Xia,
  • Qinglong Yan,
  • Huating Kong,
  • Jichao Zhang,
  • Xiaolei Zuo,
  • Jiye Shi,
  • Lihua Wang,
  • Ying Zhu,
  • Chunhai Fan

DOI
https://doi.org/10.1038/s41467-018-06749-2
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 11

Abstract

Read online

Arsenic trioxide (ATO) based therapy in solid cancers is limited. Here they repurpose nanodiamonds (NDs) as a safe and potent autophagic inhibitor to improve the efficacy of ATO-based treatment in solid tumors and show the combination therapy to work better in orthotopic liver cancer model.